Chemoinformaics analysis of 6BETA-HYDROXYSTIGMASTA-4,22-DIEN-3-ONE
Molecular Weight | 426.685 | nRot | 5 |
Heavy Atom Molecular Weight | 380.317 | nRig | 23 |
Exact Molecular Weight | 426.35 | nRing | 4 |
Solubility: LogS | -6.326 | nHRing | 0 |
Solubility: LogP | 6.148 | No. of Aliphatic Rings | 4 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 4 |
Atoms Count | 77 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 31 | No. of Aromatic Carbocycles | 0 |
nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 3 |
No. of Hydrogen atom | 46 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 29 | No. of Saturated Rings | 3 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
nHA | 2 | APOL | 80.7065 |
nHD | 1 | BPOL | 47.0155 |
QED | 0.433 |
Synth | 4.687 |
Natural Product Likeliness | 2.524 |
NR-PPAR-gamma | 0.014 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Rejected |
Golden Triangle | Rejected |
Pgp-inh | 0.886 |
Pgp-sub | 0 |
HIA | 0.007 |
CACO-2 | -4.874 |
MDCK | 0.00000782 |
BBB | 0.979 |
PPB | 0.990406 |
VDSS | 1.318 |
FU | 0.0161073 |
CYP1A2-inh | 0.033 |
CYP1A2-sub | 0.622 |
CYP2c19-inh | 0.067 |
CYP2c19-sub | 0.932 |
CYP2c9-inh | 0.131 |
CYP2c9-sub | 0.14 |
CYP2d6-inh | 0.004 |
CYP2d6-sub | 0.77 |
CYP3a4-inh | 0.31 |
CYP3a4-sub | 0.756 |
CL | 19.64 |
T12 | 0.065 |
hERG | 0.014 |
Ames | 0.021 |
ROA | 0.259 |
SkinSen | 0.019 |
Carcinogencity | 0.021 |
EI | 0.009 |
Respiratory | 0.827 |
NR-Aromatase | 0.007 |
Antiviral | No |
Prediction | 0.642971 |